Sichuan Hebang Biotechnology Corporation Limited (SHA:603077)
China
· Delayed Price · Currency is CNY 2.890
-0.010 (-0.34%)
At close: Mar 9, 2026
SHA:603077 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 23,044 | 16,372 | 20,591 | 26,524 | 28,624 | 12,117 | Upgrade
|
| Market Cap Growth | 46.50% | -20.49% | -22.37% | -7.33% | 136.22% | -4.87% | Upgrade
|
| Enterprise Value | 25,399 | 17,861 | 19,320 | 24,994 | 28,461 | 13,894 | Upgrade
|
| Last Close Price | 2.89 | 2.04 | 2.34 | 2.96 | 3.30 | 1.37 | Upgrade
|
| PE Ratio | - | 520.33 | 16.05 | 6.97 | 9.48 | 295.96 | Upgrade
|
| Forward PE | - | 14.96 | 14.96 | 14.96 | 14.96 | 14.96 | Upgrade
|
| PS Ratio | 3.01 | 1.92 | 2.33 | 2.03 | 2.87 | 2.30 | Upgrade
|
| PB Ratio | 1.23 | 0.86 | 1.02 | 1.34 | 1.96 | 1.07 | Upgrade
|
| P/TBV Ratio | 1.64 | 1.14 | 1.33 | 1.75 | 2.76 | 1.47 | Upgrade
|
| P/FCF Ratio | - | - | - | 15.53 | 19.58 | 70.55 | Upgrade
|
| P/OCF Ratio | 25.18 | 34.99 | 256.33 | 10.03 | 8.75 | 32.85 | Upgrade
|
| EV/Sales Ratio | 3.32 | 2.09 | 2.19 | 1.92 | 2.85 | 2.64 | Upgrade
|
| EV/EBITDA Ratio | 28.97 | 19.33 | 8.02 | 4.63 | 6.65 | 11.92 | Upgrade
|
| EV/EBIT Ratio | - | - | 13.59 | 5.57 | 7.80 | 26.59 | Upgrade
|
| EV/FCF Ratio | -77.79 | - | - | 14.63 | 19.47 | 80.89 | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.42 | 0.10 | 0.09 | 0.09 | 0.19 | Upgrade
|
| Debt / EBITDA Ratio | 10.19 | 8.61 | 0.81 | 0.34 | 0.32 | 1.84 | Upgrade
|
| Debt / FCF Ratio | - | - | - | 1.06 | 0.94 | 12.48 | Upgrade
|
| Net Debt / Equity Ratio | 0.11 | 0.06 | -0.05 | -0.14 | -0.03 | 0.12 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.44 | 1.14 | -0.45 | -0.51 | -0.09 | 1.11 | Upgrade
|
| Net Debt / FCF Ratio | -6.47 | -1.63 | 1.46 | -1.62 | -0.27 | 7.56 | Upgrade
|
| Asset Turnover | 0.28 | 0.32 | 0.36 | 0.62 | 0.61 | 0.36 | Upgrade
|
| Inventory Turnover | 1.60 | 1.79 | 2.11 | 5.01 | 7.60 | 4.45 | Upgrade
|
| Quick Ratio | 2.02 | 1.69 | 1.40 | 1.92 | 1.10 | 0.81 | Upgrade
|
| Current Ratio | 3.07 | 2.61 | 2.69 | 2.60 | 1.49 | 1.05 | Upgrade
|
| Return on Equity (ROE) | -1.00% | -0.36% | 6.40% | 22.15% | 23.33% | 0.03% | Upgrade
|
| Return on Assets (ROA) | -0.22% | -0.12% | 3.65% | 13.34% | 13.97% | 2.23% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.48% | -0.26% | 6.55% | 24.44% | 23.00% | 0.77% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.40% | -0.20% | 6.80% | 22.00% | 24.70% | 4.50% | Upgrade
|
| Earnings Yield | -0.42% | 0.19% | 6.23% | 14.35% | 10.54% | 0.34% | Upgrade
|
| FCF Yield | -1.42% | -3.96% | -3.64% | 6.44% | 5.11% | 1.42% | Upgrade
|
| Dividend Yield | 0.69% | 0.98% | - | 1.52% | 0.46% | - | Upgrade
|
| Payout Ratio | - | 783.94% | 36.13% | 5.20% | 2.58% | 226.52% | Upgrade
|
| Buyback Yield / Dilution | 3.60% | 2.32% | -0.10% | -3.09% | 1.10% | 1.48% | Upgrade
|
| Total Shareholder Return | 4.29% | 3.30% | -0.10% | -1.57% | 1.55% | 1.48% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.